Creative Medical Technology Holdings, Inc. (CELZ) stock
CELZNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
$0.48−0.04 (-8.36%)
Close on Nov 17, 2026Market cap $3.14MP/E –Yield –
Creative Medical Technology price to book ratio
The price-to-book ratio is market cap divided by shareholders' equity.
Creative Medical Technology's price to book ratio was 0.5× on Nov 11, 2026, against 1.2× a year earlier. Over the last 5 years it ranged from 0.4× to 24.2×, with a median of 0.8×.
Price to Book Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2026 | Nov 11, 2026 | 0.5× | −0.4 |
| 2025 | Dec 31, 2025 | 0.9× | +0.4 |
| 2024 | Dec 31, 2024 | 0.5× | −0.1 |
| 2023 | Dec 29, 2023 | 0.5× | −1.9 |
| 2022 | Dec 30, 2022 | 2.4× | – |
See a number that looks wrong?